ERBB2 and neoplasm: Perhaps evidence of this is seen in some larger studies [43] that have shown that HER2-positive tumours within the BRCA population are more frequently associated with oestrogen positivity (75% vs. 46%, p < 0.0026), with a trend towards an older age of onset (mean 48 years vs. 42 years).